Aarti Pharmalabs: Midcap Pharma Company Upgraded to 'Buy' by MarketsMOJO for Strong Financials and Technical Indicators
Aarti Pharmalabs, a midcap pharmaceutical company, has recently caught the attention of investors as its stock has been upgraded to 'Buy' by MarketsMOJO on September 9, 2024. This upgrade comes with good reason, as the company has shown strong financials and technical indicators.One of the main reasons for the 'Buy' call is the company's low Debt to Equity ratio, which is at an average of 0.10 times. This indicates a healthy financial position and the ability to manage its debt effectively.
Moreover, Aarti Pharmalabs has shown consistent long-term growth, with its Net Sales growing at an annual rate of 24.30% and Operating profit at 69.57%. This is a positive sign for investors looking for stable and sustainable growth.
From a technical standpoint, the stock is currently in a Bullish range and has shown improvement since September 6, 2024. The MACD and OBV technical factors are also Bullish, further supporting the 'Buy' call.
In terms of valuation, Aarti Pharmalabs is trading at an attractive 3.3 Enterprise value to Capital Employed ratio, with a ROCE of 16.1. This is compared to its average historical valuations, making it a potentially undervalued stock.
Looking at the company's performance, it has outperformed the market (BSE 500) with a return of 51.35% in the last year, while its profits have also increased by 12%. This is reflected in the PEG ratio of 2.3, indicating a good balance between growth and valuation.
However, as with any investment, there are risks involved. Aarti Pharmalabs may face flat results in June 2024, which could impact its stock performance. It is important for investors to keep an eye on the company's financials and market trends to make informed decisions.
Overall, Aarti Pharmalabs seems to be a promising midcap company in the pharmaceutical industry, with strong financials and technical indicators. The 'Buy' call from MarketsMOJO is a testament to its potential for growth and value for investors.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
{{text.big_txt}}
{{text .small_txt}}
{{dashverdictresult.dashboard.stock_details.short_name}}
SEND BY EMAIL
Register now to see if the stock’s characteristics match your investment style
Subscribe now to see if the stock's characteristics match your investment style
{{dashverdictresult.dashboard.risk_return_voltality.risk_type}}, {{dashverdictresult.dashboard.risk_return_voltality.return_type}}
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
| {{ value[0] }} | {{ value[1] }} | {{ value[2] }} | {{ value[3] }} |
Create your portfolio and know how much should this stock be in your portfolio
Subscribe now to know how much you should hold in this stock
We have found 2 better stocks that you can consider
{{dashverdictresult.dashboard.return_text}}
Investors Returns (3 years) –
| Period | 6M | 1Y | 2Y | 3Y |
| {{ keyd.val }} | ||||
| {{ keyd.val }} |
Quality: {{dashverdictresult.dashboard.dotsummary.q_txt}}
Valuation: {{dashverdictresult.dashboard.dotsummary.v_txt}}
Quarterly Financial Trend: {{dashverdictresult.dashboard.dotsummary.f_txt}}
Technicals: {{dashverdictresult.dashboard.dotsummary.tech_txt}}
Stock Info:
BSE – {{dashverdictresult.dashboard.stock_details.scripcode}}/ NSE – {{dashverdictresult.dashboard.stock_details.symbol}}
Market Cap – {{dashverdictresult.dashboard.priceinfo.mcap_class}} (Rs. {{dashverdictresult.dashboard.priceinfo.mcap| number :0}} cr)
Sector – {{dashverdictresult.dashboard.stock_details.ind_name}}
52 w H/L (Rs.) – {{dashverdictresult.dashboard.priceinfo.wk_high52}}/{{dashverdictresult.dashboard.priceinfo.wk_low52}}
Average vol (6M) – {{dashverdictresult.dashboard.priceinfo.vol}}
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
